Bulletin of Mathematical Biology

We present a multiscale model of HIV that couples within-host viral dynamics with population-level transmission to capture the interplay between individual infection and epidemic spread. The model is structured by treatment age, allowing viral load to influence both infectiousness and progression to AIDS. The model is fitted using both clinical data (viral load and target cell counts of treated individuals) and epidemiological data (HIV incidence, diagnoses, and AIDS classifications). We derive the basic reproduction number and establish threshold conditions for the existence and stability of disease-free and endemic equilibria. Structural identifiability is assessed via input-output equations, showing that the multiscale model is identifiable when the initial number of treated individuals is set to zero and the AIDS death rate is assumed known. Parameters are estimated sequentially: within-host parameters are obtained via nonlinear mixed-effects modeling of clinical data, followed by estimation of population-level parameters using CDC surveillance data. Numerical simulations are performed using a finite-difference scheme with Picard iteration, and practical identifiability is evaluated via Monte Carlo simulations across varying noise levels. Results indicate that current strategies are unlikely to meet the 2030 targets, while increasing diagnosis rates and reducing transmission from diagnosed individuals could significantly alter epidemic trajectories. These findings highlight the importance of multiscale modeling and identifiability in informing effective HIV intervention strategies.

Tumors consist of heterogeneous phenotypic cells, such as normoxic cells, which are highly proliferative, and hypoxic cells, which are less proliferative. Their phenotypic switching depends on tumor microenvironmental factors, such as oxygen and nutrient concentrations supplied by local blood vessels. However, during ongoing angiogenesis, the process of sprouting new blood vessels at the tumor site from pre-existing blood vessels, and how this phenotypic switching affects and impacts tumor growth, remains poorly understood. In this article, we formulate a mathematical model to elucidate the crosstalk between vasculature and tumor cellular heterogeneity during tumor progression. The model results show a strong agreement with the experimental data. Our simulation results demonstrate that ongoing angiogenesis increases tumor growth rate. In addition, we observe that the influence of hypoxic cells on phenotypic switching from normoxic to hypoxic is more pronounced than their influence on the transition from hypoxic to normoxic. Furthermore, we perform a global sensitivity analysis using the Sobol's method to assess the importance of the model's parameters. It highlights that the volume at which blood vessels attain half-maximal rate has the maximum effect on the model.

Cancer remains a global health challenge requiring sophisticated understanding of tumor-immune dynamics for effective treatment design. Mathematical oncology has emerged as a rapidly evolving interdisciplinary field that uses mathematical models to enhance our understanding of cancer dynamics, including tumor growth, metastasis, and treatment response. This paper presents a comprehensive multiscale framework integrating patient-specific data, machine learning, and optimal control for personalized immunotherapy design. We develop a hybrid model that combines deterministic dynamics with stochastic elements and time delays, capturing the inherent variability and temporal lags in biological processes. The model incorporates biologically realistic Holling Type-II functional responses and is validated against longitudinal clinical data from 100+ cancer patients and patient-derived organoid experiments. Using deep neural networks with Bayesian regularization, we learn patient-specific parameter distributions from clinical biomarkers and predict treatment responses with high accuracy. Our optimal control framework, incorporating clinical constraints and toxicity limits, generates personalized treatment protocols that stabilize otherwise unstable dynamics. The framework establishes a new paradigm for precision immuno-oncology, bridging mathematical theory, computational methods, and clinical practice. Author summaryCancer remains one of the leading causes of death worldwide, and the immune system plays a crucial role in controlling tumor growth. However, the complex interactions between tumor cells and immune cells make it difficult to predict how individual patients will respond to immunotherapy. In this work, we develop a mathematical framework that integrates patient-specific data, machine learning, and optimal control to design personalized immunotherapy strategies. Our model captures the realistic dynamics of tumor-immune interactions by incorporating biologically relevant features such as time delays (representing immune response lags) and stochastic effects (representing biological variability). Using deep learning, we estimate patient-specific parameters from clinical biomarkers, enabling personalized predictions of treatment outcomes. We validate our framework against data from over 100 cancer patients and patient-derived organoid experiments, demonstrating excellent agreement. Our optimal control approach generates personalized treatment protocols that stabilize otherwise unstable tumor dynamics, achieving 78% tumor reduction compared to 52% for standard-of-care protocols. These findings suggest that therapies targeting immunological thresholds may be as important as those directly killing tumor cells, providing a new perspective for immunotherapy design. This framework bridges mathematical theory, computational methods, and clinical practice, offering a pathway toward truly personalized cancer treatment.

Cancer progression is driven by the interplay between cancer cell phenotypic variability regulated by EMT/MET, and cell-cell and cell-matrix interactions. Starting with an individual-based model, in which every cell is characterised by its position, velocity and a continuously varying epithelial-mesenchymal phenotype, we derive, via a kinetic description and a mean-field limit, two alternative macroscopic formulations: an Euler-like system that couples mass and momentum to the phenotypic variable, and a single advection-aggregation-diffusion equation (AADE) for the cancer cell density. Both macroscopic models retain the non-local adhesion-repulsion forces, haptotactic response to an evolving ECM, and phenotype-dependent transition dynamics driven by TGF-{beta}. Numerical experiments in two spatial dimensions indicate that the macroscopic equations reproduce key scenarios obtained at the individual scale. In particular, a microscopic-macroscopic comparison shows that the AADE density reproduces acurately both the spatial localisation and the phenotypic decomposition of the individual cell population. We also demonstrate that varying only the steepness of the TGF-{beta} switch function, changes the EMT response from an almost binary epithelial-mesenchymal (EM) separation to a partial EM phenotypes. This study provides a systematic bridge from stochastic, heterogeneous cell dynamics to continuum descriptions, for investigating phenotype driven tumour invasion and supporting the choice of macroscopic models in large-scale simulations and analytical studies.

Cancer therapy balances between two competing objectives - treatment efficacy against the tumour and the risk of treatment related severe adverse events, including patient death. Most existing optimal control theory (OCT) formulations rely on optimising heuristic cost functionals that lack direct clinical interpretability. In clinical practice treatment efficacy and patient tolerability are primarily assessed through survival metrics and adverse event rates. Here we introduce the Continuous Lifetime Payoff (CLP), a novel OCT objective functional that directly links treatment decisions to patient survival. It explicitly incorporates tumour dynamics, tumour eradication, and patient mortality from tumour progression, drug-related toxicity and age. We fit age-related mortality from life tables and infer parameters from simulated survival data. The CLP provides a clinically grounded framework for optimising chemotherapy regimens.

Immune cell engagers (ICE) such as bispecific antibodies (bsAbs), within an immunological synapse, bind and link CD3 on a T cell to a target antigen (TAA) on a cancer cell, forming a trimer (CD3:bsAb:TAA complex). With sufficient trimer numbers within the synapse, the T cell can become activated and promote cancer cell killing. Elranatamab, a CD3-bispecific antibody for multiple myeloma, has received FDA and EMA filing acceptance (August 2023 and December 2023, respectively) adding to a growing list of bsAbs that are treating patients. In the drug development stages of ICE bsAbs, mechanistic modeling approaches are often used to attain a greater quantitative understanding of the modality, preclinically, and provide human pharmacokinetic and efficacious dose predictions to aide in Phase 1 trial design. To date, the majority of ordinary differential equation (ODE) trimer models treat the tumor compartment as well-mixed and trimer formation is governed by a bulk population reaction not accounting for individual synapses. This lack of discrimination can lead to imprecise analysis when analyzing results across E:T ratios using metrics like trimers per T cell or trimers per target cell. To this end we developed an ODE trimer model based on single-synapse complexes (one target cell/one immune cell) with 2D cross-linking trimer formation. We show computationally that the number of trimers per synapse is invariant to the value of the E:T ratio for a given free bsAb concentration, a property that cannot be captured by non-synapse models. A simple demonstration of this discrepancy using the well-known Betts trimer model is presented. We then apply the Betts trimer model coupled to a tumor growth inhibition (TGI) module to show that our synapse-based trimer model is easy to substitute in to model TGI, including the addition of a trimer-per-synapse activation threshold function for cell killing. Overall, our model attempts to balance mechanistic fidelity while limiting the complexity of the model.

Coupled diffusion-reaction partial differential equations (PDEs) describe biochemical network dynamics but are difficult to solve for realistic multi-species systems without combining mechanism and data. We present a multi-stage physics-informed neural network (PINN) for multi-species diffusion-reaction PDEs and apply it to two ordinary-differential-equation (ODE) reference systems: the Boehm et al. JAK-STAT5 signaling pathway and the Sturis ultradian insulin-glucose model. For STAT5 we pose a latent-species identifiability test: given sparse observations of eight species, a ten-species model that retains two deliberately withheld but mechanistically standard components--an active receptor-JAK complex and the SOCS negative-feedback inhibitor--recovers the reference trajectory and reduces mean root-mean-square error 3.1-fold relative to an eight-species model that omits them, whereas a PDE-only solution without data anchoring diverges. Because the reference is itself ODE-generated, this demonstrates identifiability against synthetic data, not the discovery of new biology. For the insulin-glucose model the same framework reproduces the [~]120-minute oscillation to 1.0% mean relative error as a benchmark on a stiff, multi-timescale oscillator; its spatial dimension is treated as a numerical construct, not a physical transport setting. A Lyapunov analysis of the STAT5 ODE returns a maximal exponent statistically indistinguishable from zero ({lambda}max {approx} 3.61 x 10-5 min-1, 5/8 trials positive; Lyapunov time [~]1.9 x 104 min, far exceeding the 240-720 min horizon), so the system is effectively non-chaotic and the relevant instability is a bounded, parameter-induced trajectory divergence. Anchoring the solution to baseline data suppresses this divergence, with the reduction growing monotonically with sampling density--from [~]15-19% at eight time points to [~]88-97% at sixty-four, depending on perturbation magnitude. The framework thus offers a data-anchored route to latent-species identifiability and divergence suppression in biochemical ODE/PDE systems, demonstrated here against synthetic reference data. Inside cells, a three-dimensional chemistry of diffusing, reacting molecules drives signaling and rhythm--dynamics that, for realistic networks, strain conventional solvers. Here a multi-stage physics-informed neural network--machine learning constrained by the governing equations--solves stiff, multi-species reaction systems from sparse data. In the JAK-STAT5 signaling pathway, a model that retains two standard but unobserved components (an active receptor complex and a negative-feedback brake) recovers a reference trajectory that a reduced model cannot--a controlled test of whether sparse data can pin down withheld pecies, not a claim of new biology. The same framework reproduces the roughly two-hour insulin-glucose rhythm to within 1% as a benchmark on a stiff oscillator. And anchoring the solution to a few dozen baseline measurements collapses parameter-induced trajectory divergence, turning a parametrically sensitive simulation into a stable one. Where mechanism and data meet, sparse measurements can constrain the structure a model would otherwise leave undetermined.

The photosynthesis-transpiration-stomatal conductance (An-E-gs) model framework is widely used for estimating photosynthesis, transpiration, and stomatal conductance in plants. The model equations are solved by numerical iteration, and the converged model values are deemed the solution. However, there has been no general guarantee that the iterative procedure converges to a solution or that the procedure leads to convergence. Building on the recent proof of the existence of a unique set of solutions, we herewith propose a numerical algorithm that is guaranteed to converge to the solution for the An-E-gs model framework. We first analytically prove that the proposed algorithm necessarily converges to a solution. We then demonstrate the convergence across contrasting combinations of leaf temperature, relative humidity, light, atmospheric CO2, and wind speed. We further demonstrate rapid convergence with the algorithm: no more than ca. 10 iterations for approximately 10-3 mol CO2 m-2 s-1 precision in net photosynthesis and no more than ca. 20 iterations for 10-7 mol CO2 m-2 s-1 precision. By guaranteeing convergence to the solution, this algorithm eliminates concerns about nonconvergence in leaf gas-exchange calculations and is expected to serve as a robust foundation for a range of studies from leaf-level gas exchange to global-scale carbon and water cycle dynamics.

Mathematical models, e.g. differential equations and stochastic processes, have gained considerable attention for understanding evolution of antibiotic resistance. However, most existing models assume standing genetic variation and do not consider the possibility of random or drug-induced mutation of reference bacterial strains. Therefore, we propose a pharmacokinetics/pharmacodynamics (PK/PD)-based continuous-time Markov chain considering the competition and mutation between sensitive and resistant bacterial within an infected host during treatment. The proposed model is approximated as a generalized birth-death process with immigration, allowing for explicit derivation of the probability resistant population establishes during treatment. Besides capturing the stochasticity of de novo emergence of a resistant bacterial strain, we explore the effects of different antibiotic modes of action, horizontal gene transfer, nutrient availability and drug pharmacokinetics on antibiotic resistance. We find that replication-targeting (biostatic) drugs suppress resistance more than death-targeting (biocidal) drugs. Like prior works, we obtain maximized resistance at intermediate drug concentrations, however the consideration of de novo mutation magnifies the superiority of higher doses in preventing resistance emergence.

Alterations in epidermal growth factor receptor (EGFR) dynamics can influence tumor initiation by changing receptor abundance, ligand-dependent activation, and downstream proliferative signaling. Mathematically linking these receptor-scale processes to population-level tumor growth remains challenging because they couple molecular, cellular, and tissue-scale dynamics. Here, we develop multiscale models that explicitly captures receptor-ligand dynamics. We analyze the dynamics of a refined version of a 3D stochastic multicellular model with explicit EGFR-EGF interactions to derive a receptor-structured continuum model in which cells are organized by active receptor clusters. This model is further reduced into a population dynamics model that tracks the mean number of active receptors. It captures the main qualitative behaviours of the higher-dimensional models while enabling analytical and numerical characterization of model-derived thresholds for sustained growth. After calibration and comparison with available in vivo tumor-growth data under EGFR overexpression, we use the model hierarchy to quantify how initiation thresholds depend on EGF availability, EGFR abundance, receptor-ligand unbinding, and genetic potential. The models predict that EGFR overexpression, stronger receptor-ligand binding, and more aggressive cell phenotypes each lower the EGF molecular counts required for sustained tumor growth. Overall, the proposed framework provides a flexible mathematical approach for connecting receptor-ligand kinetics with population-level tumor-initiation dynamics.

Diffuse gliomas are deadly because the individual tumor cells invade - they travel far from the imageable mass, so it is impossible to remove the tumor completely. On the cellular level, glioma cells seem to be in either a "go" state (in which they do not divide) or a "grow" state (in which they do not migrate). We investigate what this tiny choice has to say about the large-scale speed of the invasion front and whether the implication is sufficiently strong to rule out the classical description of the Fisher-Kolmogorov-Petrovsky-Piskunov (Fisher-KPP) type, in which a single phenotype migrates and proliferates. We derive a two-phenotype reaction-diffusion model with density-dependent switching, and we prove the cooperative (quasi-monotone) structure and the associated comparison principle and study travelling-wave solutions of the model. A leading-edge linearization gives minimal front speed as minimizer of an explicit dispersion relation, and direct simulation verifies the predicted speed. In the experimentally relevant fast switching limit, we find a closed-form expression for the speed, that is, we obtain an effective Fisher-KPP equation with rescaled diffusivity and growth rate, with the fractions of the phenotypes. The "go-or-grow" (GoG) front can move at a maximum speed of half the Fisher speed for the same single-cell motility $D$ and proliferation rate $r$, which occurs only when the cells divide their time equally between the two phenotypes. This bound is directly testable: measurement of the front speed, plus independent determination of $D$ and $r$, discriminates the two hypotheses, and in the GoG case, yields recovery of the phenotype balance. We then extend the result to anisotropic (DTI-informed) invasion along white-matter tracts and discuss implications for understanding clinical measurements of growth rate.

The global potential of a chemical reaction network has many applications and is closely related to the stochastic detailed balance. However, many fundamental questions concerning stochastic detailed balance remain unresolved, such as whether it depends on the system volume and how to construct new systems that satisfy it. In this paper, we show that stochastic detailed balance may depend on the system volume. We therefore introduce four types of stochastic detailed balance according to their dependence on volume and rate constants, and systematically investigate the relationships among them. Our results distinguish detailed balance arising from particular choices of volume and parameters from that enforced by network structure, and identify conditions under which detailed balance at one volume extends to all volumes. We further obtain a class of networks satisfying stochastic detailed balance for every volume and every positive choice of rate constants, and construct new systems whose global potentials exhibit double-well structures.

As machine learning and artificial intelligence systems are increasingly used in healthcare, rigorous evaluation of their classification performance has become critical. The F1 and F{beta} scores are widely adopted metrics for assessing performance in imbalanced biomedical data. Recently, we introduced psF1, a unified statistical framework for inference and study design for single and comparative F1 and F{beta} scores under the assumption of independent classifiers. In practice, however, benchmarking two classifiers on the same dataset creates a correlated paired setting. Ignoring this intrinsic dependency leads to overestimation of the standard error and a substantial loss of statistical power. To address this, we develop psF1pair, an advanced framework for statistical inference and power analysis that explicitly accounts for correlations between classifier pairs. Extensive simulation studies demonstrate the performance of psF1pair, and its utility is further illustrated through application to a real-world imaging classification system. As expected, higher correlation between classifiers yields narrower confidence intervals and enhanced statistical power. A freely available R package is provided to facilitate implementation, supporting accurate evaluation and study design for predictive and classification models in biomedical research.

Spatial population structure and seasonality are both central to the spread of many infectious diseases of plants, animals and humans. While seasonal forcing in transmission often plays an important role in epidemiological models of a wide range of infectious disease, and we now have some theoretical understanding of the dynamical impacts of spatial structure, the combined effects of these two ubiquitous processes has not been examined in detail. Here, we develop a novel model to explore the combined influence of spatial structure and temporal variability on disease dynamics. Spatial structure is represented using a lattice-based approach with near-neighbour interactions, while temporal variability is included through regular, seasonal, variation of the transmission rate. We use bifurcation analysis of a pair approximation of the full spatial model to identify the parameter regimes associated with qualitatively distinct dynamical behaviours. The model exhibits a remarkably wide range of complex dynamics, including limit cycles, quasi-periodic cycles, multi-year cycles, chaotic dynamics and bistability between these different states. In particular, complex dynamics occur when reproduction is predominantly local, with the dynamics depending critically on the amplitude of the seasonal transmission rate. We show how high transmission rates, high birth rates and in particular low recovery rates are requirements for complex dynamics. We predict that SI-type disease interactions in plant pathogen systems will show complex dynamics even with relatively global transmission dynamics.

The study of tissue dynamics has been stimulated during the last decades thanks to the use of quantitative descriptions, with the development of several theoretical and computational frameworks, many of them revolving around the notion of reaction-diffusion systems, eventually with additional structure variables beyond time and space. The use of structure variables can accommodate phenotypic traits. In this work, we study a family of competition models, where a given population depends on a resource (e.g. oxygen) and several populations are competing for it. Our quantitative description incorporates phenotypic traits and heterogeneity at the level of cell cycle variations, which influence replication rates via oxygen consumption. This enables us to replicate the fitness of specific subpopulations to environmental conditions (e.g. oxygen shortage or external influences). Using numerical simulations, we show that such models display dynamical pattern formation in the form of coupled travelling wave profiles that expand or retreat at the same wave speed. The full theoretical analysis of such dynamics is quite involved; to circumvent this difficulty, we introduce a quasi-stationary approximation for the resource dynamics. We find that this approximation can reproduce the overall behaviour very accurately, with the additional benefit of allowing theoretical treatment of the reduced model. In this way, we provide estimates on the wave speed which are numerically shown to be robust across a wide range of macroscopic parameters of the full model. The wave speeds are thus found to depend strongly on the proliferation rate of the fittest population, resembling a winner-takes-all dynamics.

Immune checkpoint blockade (ICB) therapy has revolutionized cancer treatment, though it is still effective in only about 20-40% of patients. To increase the efficacy of ICB therapy, combinations of ICB antibodies such as anti-PD1 and anticoagulants (e.g., thrombin inhibitors) have been studied in preclinical mouse models and clinical trials. We developed a Bliss-type analysis to quantify the synergy between anti-PD1 and dabigatran etexilate using published tumor growth data from a mouse model. We then developed a minimal mechanistic computational model to quantitatively study the synergy between anti-PD1 and the thrombin inhibitor dabigatran etexilate in a published study (Metelli et al.) of a preclinical mouse model of colon cancer. Our model included tumor cells, CD8+ T cells, and the pleiotropic cytokine TGF{beta}, whose production in platelets is influenced by thrombin, and described a potential mechanism of interplay among these components in the tumor microenvironment. We performed nonlinear mixed-effects modeling to capture mouse-to-mouse variation in tumor growth under different treatment conditions. The estimated parameter values pointed to several underlying mechanisms of synergy, including increased expansion of CD8+ T cells in the tumor microenvironment in the presence of anti-PD1 and dabigatran etexilate. These predictions can be further validated in future experiments. Thus, the combination of longitudinal tumor growth data, mechanistic population dynamics modeling, and nonlinear mixed-effects modeling can be used to study synergy between ICB and other drugs in controlling tumor growth.

Cell shape and mechanics are intricately connected and tightly regulated by mechanochemical events including biochemical signaling, cytoskeletal remodeling, and plasma membrane mechanics. While experimental advances in microscopy have shed light on the intricate coordination involved in cell shape change in response to different cues, the ability to conduct three-dimensional simulations in realistic geometries remains an open computational challenge. In this work, we develop a finite-element framework that incorporates advection-diffusion-reaction equations coupled with equations governing the kinematics of a deformable interface representing the cell membrane. We applied this framework to three distinct coupled mechanochemical systems, each governed by geometric partial differential equations, resulting in large deformations of the interface. In all three examples, our simulations revealed the emergence of feedback between cellular signaling, cytoskeletal organization, and cell shape. In our first two sets of simulations, we observed that cell migration and neutrophil protrusion were regulated by membrane tension-mediated feedback. In our final application, we predicted shape changes of a dendritic spine starting from a realistic geometry, and found that the complex shape of the spine gives rise to localized regimes of actin cytoskeleton remodeling not previously observed with idealized geometries. Thus, our finite-element framework allows us to generate new mechanistic insights for biophysical problems.

Malaria and diabetes represent two globally significant metabolic disorders whose co-occurrence leads to complex, poorly understood pathophysiological interactions. Plasmodium infection disrupts glucose homeostasis through parasite-driven glucose consumption, inflammatory cytokine production, and pancreatic /{beta}-cell dysfunction, while diabetes impairs host immunity and increases malaria susceptibility. To date, no mathematical framework has captured the bidirectional coupling between these systems. Here we extend the insulin-glucose-glucagon (IGG) model of Dalton et al.\ (2026) by introducing a fourth state variable representing parasite load, incorporating malaria-induced insulin suppression, parasite-driven glucose consumption, inflammatory gluconeogenesis, bidirectional glucagon dysregulation, and insulin-dependent immune enhancement of parasite clearance. We establish positivity, boundedness, existence and uniqueness of steady states, local stability via Routh-Hurwitz criteria, global stability via Lyapunov functions, and sensitivity analysis of parameters driving hypoglycemia risk. Numerical simulations characterise the model across healthy, diabetic, and co-infected states. They show that parasite-driven glucose consumption and inflammatory gluconeogenesis act antagonistically on circulating glucose, that insulin-enhanced immunity lowers peak parasitemia through a saturating clearance term, and that increasing the half-life of exogenous insulin raises hypoglycemia risk in all host states. These mechanisms provide testable hypotheses for the clinical management of malaria-diabetes patients and identify potential therapeutic targets (TNF- blockade, glucagon analogues) for mitigating co-infection morbidity.

Diaphorina citri is the primary vector of Huanglongbing (HLB), a devastating disease that affects global citrus production. Effective biological control using the parasitoid Tamarixia radiata represents a sustainable alternative to chemical insecticides, but its efficacy depends heavily on environmental variables and resource availability. In this work, we develop a four-population mathematical model to analyze the dynamics of D. citri in the presence of T. radiata, a known parasitoid. Our model incorporates the cyclical and periodic behavior of citrus flushing (new shoots), providing a realistic representation of resource-limited dynamics as observed in field conditions. Through comparative simulations of three scenarios, without parasitoid, a single initial introduction, and periodic augmentative releases, we characterize and compare the impact of T. radiata as a biological control agent. Our results show that periodic releases maintain pest suppression, whereas a single introduction only delays pest recovery. By aligning theoretical modeling with ecological reality, this framework supports the role of T. radiata in pest suppression and provides a baseline for future work on optimal and cost-effective release strategies.

Understanding and predicting extinction risk is a central challenge in population biology. Mathematical models incorporating Allee thresholds are commonly used to understand population dynamics and to assess extinction risks. Inaccurate predictions can have serious consequences for conservation management. In this simulation study, we develop a likelihood-based inference and prediction workflow to estimate parameters, including the Allee threshold and population diffusivity parameters, using noisy count data generated using a well-defined discrete model. Although parameters are identifiable according to commonly used criteria, the accuracy of resulting predictions depends strongly on the quantity, quality, collection time and spatial resolution of the data. Our workflow demonstrates that seemingly reliable parameter estimates can lead to inaccurate predictions, highlighting the need for careful consideration of data quality and quantity to guide extinction-risk modelling and prediction. Open source software is provided on GitHub to replicate and extend all results considered.